Literature DB >> 16232102

Associations between reproductive and menstrual factors and postmenopausal androgen concentrations.

Jessica Chubak1, Shelley S Tworoger, Yutaka Yasui, Cornelia M Ulrich, Frank Z Stanczyk, Anne McTiernan.   

Abstract

BACKGROUND: Reproductive and menstrual characteristics, as well as high circulating estrogen and androgen concentrations, are associated with the risk of breast and ovarian cancer in postmenopausal women. To explore possible etiological relationships between menstrual and reproductive characteristics and cancer risk, we examined associations between menstrual and reproductive factors and serum concentrations of total testosterone, free testosterone, androstenedione, dehydroepiandrosterone (DHEA), and dehydroepiandrosterone sulfate (DHEA-S).
METHODS: This study was conducted in 167 postmenopausal women, using data from the pre-randomization visit of an exercise clinical trial. Participants were sedentary, overweight/ obese, and not on hormone therapy.
RESULTS: DHEA-S concentrations were 42% higher, total testosterone concentrations were 35% lower, and free testosterone concentrations were 23% lower in women with both ovaries removed compared with those with both remaining (p = 0.01, p = 0.01, and p = 0.03, respectively). Women who had used herbal therapy in the past had, on average, 25% higher concentrations of total and free testosterone than women who had never used these herbal therapies (p = 0.03 and p = 0.004, respectively). No other significant associations were detected.
CONCLUSIONS: Overall, this study does not support the hypothesis that reproductive or menstrual factors, with the exception of oophorectomy status, are associated with postmenopausal androgen concentrations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16232102     DOI: 10.1089/jwh.2005.14.704

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  6 in total

1.  The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women.

Authors:  Kim N Danforth; A Heather Eliassen; Shelley S Tworoger; Stacey A Missmer; Robert L Barbieri; Bernard A Rosner; Graham A Colditz; Susan E Hankinson
Journal:  Int J Cancer       Date:  2010-01-01       Impact factor: 7.396

2.  Effect of a 12-month exercise intervention on serum biomarkers of angiogenesis in postmenopausal women: a randomized controlled trial.

Authors:  Catherine Duggan; Liren Xiao; Ching-Yun Wang; Anne McTiernan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-05       Impact factor: 4.254

3.  Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer.

Authors:  Tianhui Chen; Helja-Marja Surcel; Eva Lundin; Marjo Kaasila; Hans-Ake Lakso; Helena Schock; Rudolf Kaaks; Pentti Koskela; Kjell Grankvist; Goran Hallmans; Eero Pukkala; Anne Zeleniuch-Jacquotte; Paolo Toniolo; Matti Lehtinen; Annekatrin Lukanova
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-12-21       Impact factor: 4.254

4.  The association of reproductive and lifestyle factors with a score of multiple endogenous hormones.

Authors:  Amy L Shafrir; Xuehong Zhang; Elizabeth M Poole; Susan E Hankinson; Shelley S Tworoger
Journal:  Horm Cancer       Date:  2014-07-22       Impact factor: 3.869

5.  Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.

Authors:  Phuong L Mai; Austin Miller; Amanda Black; Roni T Falk; John F Boggess; Katherine Tucker; Ashley R Stuckey; Gustavo C Rodriguez; Cheung Wong; Thomas T Amatruda; Kelly J Wilkinson; Susan C Modesitt; S Diane Yamada; Kristin L Bixel; Gretchen E Glaser; Peter G Rose; Mark H Greene; Mark E Sherman
Journal:  Am J Obstet Gynecol       Date:  2022-02-22       Impact factor: 10.693

6.  Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones.

Authors:  Mark E Sherman; M Patricia Madigan; James V Lacey; Montserrat Garcia-Closas; Nancy Potischman; Joseph D Carreon; Patricia Hartge; Louise A Brinton
Journal:  Gynecol Oncol       Date:  2007-08-27       Impact factor: 5.482

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.